Recombination-activating gene 1 (Rag1) and Rag2 enzymes are required for T cell receptor assembly and thymocyte development. The mechanisms underlying the transcriptional activation and repression of Rag1 and Rag2 are incompletely understood. The zinc-finger protein, Zfp608, represses Rag1 and Rag2 expression when expressed in thymocytes blocking T-cell maturation. Here we show that the related zinc-finger protein, Zfp609, is necessary for Rag1 and Rag2 expression in developing thymocytes. Zfp608 represses Rag1 and Rag2 expression indirectly by repressing the expression of Zfp609. Thus, the balance of Zfp608 and Zfp609 plays a critical role in regulating Rag1 and Rag2 expression, which may manifest itself not only during development of immature thymocytes into mature T cells but also in generation of the T-cell arm of the adaptive immune system, which does not fully develop until after birth.
INTRODUCTION
The assembly of antigen receptor genes by T and B lymphocytes represents one of the fundamental features of the adaptive immune response in vertebrates. This process is required to generate enormous diversity in the immunoglobulin and T cell receptor repertoire, which is necessary to recognize virtually any encountered pathogen. [1] [2] [3] The processes involved in the ordered assembly of antigen receptor genes by V(D)J recombination are catalyzed by the recombination-activating gene (RAG)-1/RAG-2 enzymes and are unique to precursor T and B lymphocytes. [4] [5] [6] [7] However, the mechanisms that control the activation and repression of Rag genes during precursor lymphocyte and fetal development remain unclear. 8, 9 These precisely orchestrated pathways are critical to the development of a functioning adaptive immune system.
In contrast to most organs, the adaptive immune system does not fully develop until after birth (3-4 weeks postpartum in mice and 2-4 years in humans). [10] [11] [12] [13] The reasons for this delayed development remain unclear. One possibility is that development of a fully functional adaptive immune system in utero or early in postnatal life would trigger deleterious responses to maternal antigens. Alternatively, the repertoire of self-antigens in fetal or neonatal development may be vastly different than those expressed in adults. Thus, efficient immune development in neonates may lead to the production of potential autoreactive clones in adults, which may also produce a highly skewed immunoglobulin and T cell receptor repertoire. Therefore, active mechanisms may be in place to delay development of the adaptive immune system until later in postnatal life.
We developed a congenic strain (ZORI (Zfp608 overexpressing Rag insufficient)) with defects in Rag1 and Rag2 expression, thymocyte maturation and peripheral T-cell homeostasis. 14, 15 This mutation maps to a locus on chromosome 18 that contains a single known gene, Zfp608. In wild-type mice, Zfp608 is highly expressed in neonatal thymus but is extinguished after birth. In contrast, ZORI mice sustain thymocyte expression of Zfp608 throughout life. The ZORI mutation produces a thymocyte-intrinsic developmental defect. Overexpression of a Zfp608 complementary DNA in thymocytes by transient transfection severely impairs Rag expression, providing an underlying mechanism for defects in ZORI thymocyte development. This ZORI defect is similar to that observed in Omenn Syndrome. 16 ZORI mice and Omenn syndrome cases both have limited levels of V(D)J recombination due to either reduced Rag expression or the presence of hypomorphic mutations in Rag resulting in reduced Rag activity, respectively. This points to the fine balance of Rag expression and timing required for normal development and function of the immune system. A further manifestation of Omenn syndrome is development of autoimmune symptoms thought to result from the generation of a restricted T cell receptor or B cell receptor repertoire, indicating that reduced Rag function can produce additional immune phenotypes such as autoimmunity.
Our previous studies do not address whether Zfp608 represses Rag expression directly by, for example, targeting the Rag locus or indirectly by altering the expression or interfering with the function of transacting factors that directly regulate Rag expression. Based upon amino-acid sequence conservation, Zfp609 is the closest relative to Zfp608. This high level of shared identity supports the notion that Zfp608 and Zfp609 genes evolved from a common ancestral gene. [17] [18] [19] The expression and function of ancestrally related genes may change through evolution or may remain redundant. Therefore, we hypothesized that Zfp609 may also regulate Rag gene expression during T-cell development. Our results demonstrate that Zfp608 negatively regulates Zfp609 expression and that Zfp609 expression is necessary for Rag expression by thymocytes. 1 
RESULTS
Reciprocal expression of Zfp608, Zfp609, Rag and Aire in the thymus Zinc-finger proteins are transcriptional regulators. 20 Previous studies have shown that Zfp608 reduced Rag expression in thymocytes and impaired T-cell development. Based upon a total percent identity of 43.6% and a total sequence similarity of 57.6%, Zfp609 is the closest relative to Zfp608 (Supplementary Figure 1) . A C2H2 zinc-finger and domain (D2) are conserved in each protein from vertebrates to deuterostomes. 17 This domain conservation, coupled with percent identity and percent similarity, supports the notion that Zfp608 and Zfp609 evolved from a common ancestral gene. 18, 19 Expression and function of ancestrally related genes may change through evolution or may remain redundant with similar function. ZORI thymocytes constitutively express Zfp608 and reduced levels of Rag. To address the functional relationships between Zfp608, Zfp609 and Rag expression, we purified total thymocyte RNA from 6-week-old homozygous ZORI or BALB/c mice (n ¼ 3). Using real-time PCR, we measured thymocyte expression of Zfp608, Zfp609, Rag1 and Rag2 relative to Gapdh (Figures 1a-d) . As expected, ZORI thymocytes expressed higher levels of Zfp608 than BALB/c thymocytes. In contrast, BALB/c thymocytes expressed higher levels of Zfp609 than ZORI thymocytes. Thus, Zfp608 expression negatively correlates with Rag expression, whereas Zfp609 expression positively correlates with Rag expression.
Histone modification and remodeling is a dynamic strategy employed by all eukaryotes to regulate gene expression. Brakeless, the drosophila ortholog of Zfp608, is part of a corepressor complex that recruits histone deacetylases to suppress gene expression. 17 The conservation of function between brakeless and Zfp608 has not been fully elucidated. We postulated that ZORI thymocytes might exhibit decreased histone acetylation at the Rag promoter relative to BALB/c thymocytes. To test this, we used chromatin immunoprecipitation to compare histone 4 acetylation at Rag promoters in ZORI and BALB/c thymocytes (n ¼ 3). We found that levels of histone 4 acetylation were greater at both Rag promoters in BALB/c compared with ZORI thymocytes (Figures 1e and f) . These results support the notion that Zfp608 promotes deacetylation of Rag promoters in ZORI thymocytes.
Rag mutations result in a loss of Aire expression by thymic epithelium. It is not known if decrease in Rag expression in the absence of Rag mutation, as seen in ZORI thymocytes, is sufficient to result in decreased Aire expression. To address this possibility, we determined levels of Aire expression in ZORI and BALB/c thymic epithelia. We found that levels of Aire expression were markedly reduced in ZORI thymic epithelia compared with BALB/c thymic epithelia (Figure 1g ). These results indicate that decreased Rag expression in thymocytes is associated with a decrease in Aire expression in thymic epithelia. Whether Aire deficiency is associated with physical manifestations of the ZORI genotype is not known.
Zfp608 represses Zfp609 expression The VL3-3M2 thymocyte cell line constitutively expresses Rag genes and has been employed to investigate mechanisms of Rag regulation and thymocyte differentiation. We compared levels of Zfp608 and Zfp609 expression in VL3-3M2 cells with NIH-3T3 fibroblasts. We isolated total RNA from NIH-3T3 fibroblasts and VL3-3M2 thymocytes and used real-time PCR to compare levels of Zfp608, Zfp609, Rag1 and Rag2 relative to Gapdh (n ¼ 3). NIH-3T3 fibroblasts expressed high levels of Zfp608, whereas it was undetectable in VL3-3M2 thymocytes (Figure 2a ). In contrast, Zfp609 transcript levels were higher in VL3-3M2 cells than in NIH-3T3 fibroblasts ( Figure 2b ). As reported, Rag1 and Rag2 were expressed in VL3-3M2 thymocytes but these transcripts were undetectable in NIH-3T3 fibroblasts (Figures 2c and d). As with thymocytes, these data demonstrate that expression of Rag is associated with high levels of Zfp609 expression and low levels of Zfp608 expression in VL3-3M2 cells.
From these data, we envision two possibilities: Zfp608 directly represses Rag gene expression or it directly represses expression of Zfp609, which, in turn, is required for Rag expression. To better distinguish between these two possibilities, we generated VL3-3M2 cells stably transfected with a vector constitutively expressing Zfp608, termed VL3-3M2-Zfp608. Total RNA was isolated from VL3-3M2 and VL3-3M2-Zfp608 cells and analyzed by real-time PCR (n ¼ 4). VL3-3M2-Zfp608 cells had a higher level of Zfp608 expression compared with VL3-3M2 cells (Figure 3a ). Rag1 and Rag2 transcript levels were reduced in VL3-3M2-Zfp608 cells compared with VL3-3M2 cells (Figures 3b and c) . There was also a marked reduction in Zfp609 transcript levels in VL3-3M2-Zfp608 cells ( Figure 3d ). We observed a consistent relationship between expression levels of Rag1, Rag2 and Zfp609 relative to Zfp608 (Figure 3e ). The changes in Rag1, Rag2 and Zfp609 expression levels were comparable relative to Zfp608. These results resemble the expression patterns observed in ZORI thymocytes and are consistent with the possibility that Zfp608 negatively regulates Zfp609 expression in this thymocyte cell line. These results also suggest that there is a proportional relationship between expression levels of Zfp609, Rag1 and Rag2.
Zfp609 is a positive regulator of Rag expression Our data demonstrate that Zfp608 negatively regulates Zfp609 expression in thymocytes, but do not address whether Zfp609 is a positive regulator of Rag expression. To test this possibility, we introduced a Zfp609 expression plasmid or empty vector control into VL3-3M2-Zfp608 cells by transfection with diethylaminoethanol-dextran (DEAE-dextran) and monitored Rag expression (n ¼ 4). Transfection of a Zfp609 expression vector increased Zfp609, Rag1 and Rag2 expression in VL3-3M2-Zfp608 cells (Figures 4a-c) . There was no difference in Zfp608 expression in empty vector-transfected controls versus Zfp609 expression vector-transfected cells (Supplementary Figure 2) . We compared the transcript levels of Rag1 and Rag2 relative to Zfp609 and Zfp608 (Figure 4d ). We observed that expression levels of Rag1 and Rag2 relative to expression levels of Zfp609 were consistent between controls and Zfp609-transfected cells. Thus, we conclude that Zfp609 is necessary for Rag1 and Rag2 expression in VL3-3M2-Zfp608 cells and that Zfp608 represses Zfp609 and its downstream targets Rag1 and Rag2.
These results prompted us to consider whether Zfp609 is a positive regulator of Rag expression. Accordingly, we determined if a reduction in Zfp609 altered Rag expression. To achieve this, we employed a small interfering RNA (siRNA) strategy for targeted knockdown of Zfp609. This was performed in both VL3-3M2 and BALB/c thymocytes (n ¼ 5) using a scrambled/nonspecific siRNA and a Zfp609-specific siRNA. The knockdown proved to be effective based on reduced Zfp609 expression in VL3-3M2 thymocytes transfected with the Zfp609-specific siRNA compared with scrambled/nonspecific controls (Figure 5a ). siRNA-mediated knockdown of Zfp609 also produced a reduction in both Rag1 and Rag2 transcript levels in VL3-3M2 thymocytes (Figures 5b and c) . Knockdown of Zfp609 similarly attenuated Zfp609, Rag1 and Rag2 transcripts in BALB/c thymocytes (Figures 5e-g ). We observed an increase in Rag1 and Rag2 relative to Zfp609 in siRNA-targeted VL3-3M2 cells and BALB/c thymocytes compared with scrambled controls (Figures 5d and h ). This suggests that the knockdown was specific for Zfp609 and that the corresponding reduction in Rag1 and Rag2 did not occur at the same magnitude as Zfp609. We conclude from these experiments that Zfp609 is a positive regulator of Rag1 and Rag2 gene expression in both VL3-3M2 and BALB/c thymocytes. Zfp608 inhibits the Zfp609 promoter and Zfp609 activates the Rag promoter We have shown that Zfp609 positively regulates Rag but is negatively regulated by Zfp608. We therefore hypothesized that Zfp608 directly represses the Zfp609 promoter. The transcriptional start site and Zfp609 promoter were identified using multispecies conservation. 19 The Zfp609 promoter was cloned into a luciferase reporter vector and introduced into VL3-3M2 thymocytes by transient transfection with or without a Zfp608 expression vector. Co-transfection of the Zfp608 expression vector with the Zfp609 promoter luciferase reporter led to a reduction of Zfp609 promoter activity (Figure 6a ). These data demonstrated that Zfp608 represses Zfp609 promoter activity, which most likely contributes to Zfp608-dependent reduction of Zfp609 transcript levels.
Our data also show that Zfp609 is a positive regulator of Rag expression. Therefore, we sought to determine if Zfp609 positively regulated Rag promoter activity. To address this, we cotransfected VL3-3M2 cells with a Rag1 or Rag2 promoter luciferase vector with or without a vector constitutively expressing Zfp609. 21, 22 Cells transfected with the Zfp609 expression vector and the Rag1 promoter construct exhibited increased Rag1 promoter activity compared with cells transfected with the Rag1 promoter luciferase reporter construct alone (Figure 6b ). There was little change in cells transfected with Zfp609 and the Rag2 promoter luciferase reporter construct (not shown). To address specificity of effect, VL3-3M2 cells were co-transfected with a human interferon-g (IFNG) luciferase reporter vector with or without Zfp608 and Zfp609 expression vectors (Supplementary Figure 3) . The presence of Zfp608 or Zfp609 had no effect on IFNG reporter activity. These results demonstrated that Zfp609 directly stimulates activity of the Rag1 promoter.
DISCUSSION
Zfp608 is reciprocally expressed in thymocytes when compared with Zfp609 and Rag. Conversely, Zfp609 and Rag are coordinately expressed in all cell systems we examined. In keeping with these expression patterns, we now show that Zfp608 is a negative regulator of Zfp609 expression, whereas Zfp609 is a positive regulator of Rag expression. Promoter activity assays demonstrate that Zfp608 directly targets the Zfp609 promoter and that Zfp609 directly targets the Rag1 promoter. Ectopic expression of Zfp609 is sufficient to overcome Zfp608-mediated repression of Rag1 and Rag2 and siRNA-mediated knockdown of Zfp609 is sufficient to block Rag expression in both cell lines and developing thymocytes. We conclude from these studies that Zfp609 is necessary for Rag expression in developing T cells and that Zfp608 blocks Rag expression and T-cell development via targeting the Zfp609 gene.
Rag1 and Rag2 expression are coordinately regulated during T-cell differentiation; however, the underlying transcriptional mechanisms are incompletely understood. These genes are linked in the genome but each has a unique promoter that binds distinct transcription factors. A common transcription factor capable of activating or repressing both genes has not been identified. For example, Ikaros, E2A and NF-Y activate the Rag1 promoter, and Pax5, Myb, Lef1 and GATA-3 activate the Rag2 promoter. 23 Our results show that Zfp609 is necessary for both Rag1 and Rag2 expression in developing T cells and that Zfp609 directly activates the Rag1 promoter. Zfp609 did not directly activate the Rag2 promoter. This result suggests that Zfp609 stimulates Rag2 expression through a regulatory sequence outside of the promoter region tested or through an unidentified interaction. This is plausible considering that several cis-regulatory sequences 
Interplay between Zfp609 and these other transcription factors may be necessary to achieve the known oscillations of Rag gene expression during thymocyte differentiation as well as regulation of Rag during fetal and adult development. Our results clearly demonstrate that Zfp609 is necessary for Rag expression by developing T cells and that Zfp608 represses Zfp609 expression. Thus, a likely mechanism for Zfp608-mediated repression of Rag expression is via repression of Zfp609 expression. However, our results cannot rule out the possibility that other mechanisms may contribute to Zfp608-mediated repression of Rag expression. For example, Zfp608 may also directly repress Rag expression or may compete with Zfp609 for access to the Rag locus. Alternatively, the drosophila ortholog of Zfp608, brakeless, is a transcriptional repressor by virtue of its ability to recruit histone deacetylase complexes to genomic loci. 17, 24 Thus, one additional mode of action is that Zfp608 may recruit histone deacetylases to the Zfp609 locus and/or the Rag locus. In a similar vein, Zfp609 may oppose the actions of Zfp608 by recruiting histone acetyl transferases to the Rag locus to activate Rag gene expression. Additional investigations will be necessary to distinguish among these alternate possibilities.
Complete Rag deficiency (Rag À / À ) or murine hypomorphic Rag mutations identical to those seen in humans with Omenn syndrome result in markedly reduced expression of Aire. Low expression of the AIRE transcription factor contributes to the pathogenesis and autoimmune manifestations in this murine model of Omenn syndrome. ZORI mice, which exhibit reduced Rag expression to B10% of normal levels, also have severely depressed levels of Aire expression similar to levels associated with either complete Rag deficiency (Rag À / À mice) or hypomorphic Rag mutations. Altered Aire expression in ZORI mice may produce additional autoimmune manifestations contributing to their poor health. In addition, mutations affecting expression of function of ZNF608 or ZNF609 (human equivalents of murine Zfp608 or Zfp609) may also produce immunodeficiency syndromes or autoimmune syndromes in humans similar to Omenn syndrome.
MATERIALS AND METHODS Mice
ZORI and BALB/c mice were housed in a nonsterile rodent facility at Vanderbilt University. Antibiotic treatment was administered with sulfamethoxazole (40 mg l RNA isolation, complementary DNA synthesis and real-time PCR Total RNA was purified from thymus or cell lines with Tri Reagent (Ambion, Grand Island, NY, USA) according to the manufacturer's instructions. The washed RNA pellet was allowed to air dry and dissolved in RNAse-free water. Complementary DNA was generated from total RNA using Superscript III First-Strand Synthesis System for RT-PCR (Life Technologies, Grand Island, NY, USA) according to the manufacturer's suggested protocol using oligo(dt) primers. Transcript levels of individual genes were determined by the standard ABI 7300 Real-time PCR Machine protocol using the following Taqman gene expression assays (Life Technologies) Zfp608: Mm00558913_m1, Zfp609: Mm00553138_m1, Rag1: Mm01270936_m1, Rag2: Mm01270938_m1 and Gapdh: Mm99999915_g1.
Thymus isolation
Thymocytes and thymic epithelial cells were isolated by mechanical disruption of the thymus and differential centrifugation.
Generation of VL3-3M2-Zfp608 cells VL3-3M2 cells were transfected with a Zfp608 expression plasmid under the control of the CMV promoter using Lipofectamine 2000 (Life Technologies) according to the manufacturer's recommendations. The Zfp608 expression vector was previously generated and described by Zhang et al.
14 Stable transfectants were selected with G418 Sulfate (Mediatech Inc., Manassas, VA, USA).
Transient transfections
The DEAE-dextran method was used for transient transfections into VL3-3M2 or VL3-3M2-Zfp608 cells. 25 In brief, cells were incubated in 1 ml Trisbuffered saline containing 0.5 mg DEAE-dextran and 5 mg plasmid DNA for 10 min at room temperature. Cells were washed and incubated in complete culture media containing 100 mM chloroquine at 37 1C for 1 h. After incubation, cells were pelleted, washed and incubated in complete culture until RNA isolation. The plasmid used to transiently express Zfp609 was Clone ID: 3592524 (Open Biosystems, Lafayette, CO, USA). This plasmid contains Zfp609 in the pCMV-SPORT6 vector.
Zfp609, Rag1 and Rag2 promoter cloning 
Rag2
Promoter Reverse: 5 0 -GATATCATTGGACCTACCTGAAGGC-3 0 . The above oligonucleotides were used as primers and genomic BALB/c DNA as template. The PCR product was cloned into the pGEMT-EASY vector for sequencing verification. The correct clone was excised using SacI and EcoRV and ligated into the pGL4.10 luciferase vector (Promega, Madison, WI, USA).
Chromatin immunoprecipitation
Chromatin immunoprecipitation assays were performed as previously described. 26 In brief, 10-20 Â 10 6 cells were fixed in 1% formaldehyde for 12 min at room temperature on a platform rocker. After fixation, cells were then quenched with 135 mM glycine followed by two washed with ice-cold phosphate-buffered saline. Cells were resuspended in lysis buffer (50 mM Tris-HCl, 10 mM EDTA, 1% sodium dodecyl sulfate) containing protease inhibitors PMSF, Pepstatin and Aprotinin. Following sonication, chromatin fractions were precleared with protein A/G sepharose beads for 1 h at 4 1C. Chromatin was incubated overnight at 4 1C with experiment-specific primary antibodies. Immune complexes were bound to protein A/G sepharose beads for 2 h followed by washing with low-salt buffer, high-salt buffer, lithium chloride buffer and Tris-EDTA buffer. Bound complexes were isolated by incubation in elution buffer (1% sodium dodecyl sulfate and 0.1 M Na 2 HCO 3 ) for 1 h at room temperature. Bound DNA was harvested by overnight incubation at 65 1C in proteinase K. DNA samples were purified by phenol/chloroform extraction followed by ethanol precipitation and resuspended in water. Samples were analyzed as previously described.
14 Oligonucleotide primers used were as follows: Rag1: Forward, 5 0 -CATTCTCAGGAGATGAAATGACAGC-3 0 , Reverse, 5 0 -GCAGCTTGGTTGTTAACACTC-3 0 , Rag2: Forward, 5 0 -AAGCTTAAGACAGTCATTTTTTGTGG-3 0 , Reverse, 5 0 -ATTGGACCTACCTGAAGGC-3 0 .
siRNA knockdowns siRNAs specific for Zfp609 were obtained from Ambion (ID: s103186, s103185, s103184). Lyophilized siRNAs were resuspended per manufacturer's recommendation to 100 mM stock concentrations. siRNAs were introduced into thymocytes using Amaxa Nucleofactor electroporation (Lonza, Allendale, NJ, USA). In brief, 5 Â 10 6 murine thymocytes or 1 Â 10 6 VL3-3M2 cells were resuspended in 100 ml Nucleofector Solution. Then, 200 nM of gene-specific siRNA was mixed with the cell solution. The siRNAcell solution was transferred to an Amaxa cuvette and electroporated on Nucleofector program X-001. Cells were allowed to recover and cultured for 24 h before RNA was isolated for analysis. All siRNA knockdown experiments were done in triplicate.
Luciferase assay
Luciferase was measured using the Dual-Luciferase Reporter Assay (Promega). In brief, transfected cells were pelleted and lysed in 100 ml 5 Â Passive lysis buffer after being cultured for 24 h. The lysate was then added to a luminometer tube containing 100 ml of LAR solution. The luciferase level was immediately read on the TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA, USA). All luciferase assay experiments were performed in triplicate.
